Ziegler MJ, Babcock HH, Welbel SF, Warren DK, Trick WE, Tolomeo P, Omorogbe J, Garcia D, Habrock-Bach T, Donceras O, Gaynes S, Cressman L, Burnham JP, Bilker W, Reddy SC, Pegues D, Lautenbach E, Kelly BJ, Fuchs B, Martin ND, Han JH, CDC Prevention Epicenters Program. Stopping Hospital Infections with Environmental Services (SHINE): A Cluster-Randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-Resistant Organisms in the Intensive Care Unit. Clin Infect Dis. 2022 Feb 1. Available from: http://dx.doi.org/10.1093/cid/ciac070 PMID: 35100614

Zhang HL, Kelly BJ, David MZ, Lautenbach E, Huang E, Bekele S, Tolomeo P, Reesey E, Loughrey S, Pegues D, Ziegler MJ, CDC Prevention Epicenters Program. SARS-CoV-2 RNA persists on surfaces following terminal disinfection of COVID-19 hospital isolation rooms. Am J Infect Control. 2022 Jan 30. Available from: http://dx.doi.org/10.1016/j.ajic.2022.01.014 PMID: 35108581

Marques Andrew D., Sherrill-Mix Scott, Everett John K., Reddy Shantan, Hokama Pascha, Roche Aoife M., Hwang Young, Glascock Abigail, Whiteside Samantha A., Graham-Wooten Jevon, Khatib Layla A., Fitzgerald Ayannah S., Moustafa Ahmed M., Bianco Colleen, Rajagopal Swetha, Helton Jenna, Deming Regan, Denu Lidiya, Ahmed Azad, Kitt Eimear, Coffin Susan E., Newbern Claire, Mell Josh Chang, Planet Paul J., Badjatia Nitika, Richards Bonnie, Wang Zi-Xuan, Cannuscio Carolyn C., Strelau Katherine M., Jaskowiak-Barr Anne, Cressman Leigh, Loughrey Sean, Ganguly Arupa, Feldman Michael D., Collman Ronald G., Rodino Kyle G., Kelly Brendan J., Bushman Frederic D., Goff Stephen P. SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021. MBio. American Society for Microbiology; 2022;0(0):e03788–21. Available from: https://doi.org/10.1128/mbio.03788-21

Ziegler MJ, Huang E, Bekele S, Reesey E, Tolomeo P, Loughrey S, David MZ, Lautenbach E, Kelly BJ, CDC Prevention Epicenters Program. Spatial and temporal effects on SARS-CoV-2 contamination of the healthcare environment. Infect Control Hosp Epidemiol. 2021 Dec 27;1–16. Available from: http://dx.doi.org/10.1017/ice.2021.530 PMID: 34955111

Ziegler MJ, Huang E, Bekele S, Reesey E, Tolomeo P, Loughrey S, David MZ, Lautenbach E, Kelly BJ, CDC Prevention Epicenters Program. Spatial and temporal effects on severe acute respiratory coronavirus virus 2 (SARS-CoV-2) contamination of the healthcare environment. Infect Control Hosp Epidemiol. Cambridge University Press; 2021 Dec 27;1–6. Available from: http://dx.doi.org/10.1017/ice.2021.530 PMCID: PMC8755533

Marques AD, Sherrill-Mix S, Everett J, Reddy S, Hokama P, Roche AM, Hwang Y, Glascock A, Whiteside SA, Graham-Wooten J, Khatib LA, Fitzgerald AS, Moustafa AM, Bianco C, Rajagopal S, Helton J, Deming R, Denu L, Ahmed A, Kitt E, Coffin SE, Newbern C, Mell JC, Planet PJ, Badjatia N, Richards B, Wang Z-X, Cannuscio CC, Strelau KM, Jaskowiak-Barr A, Cressman L, Loughrey S, Ganguly A, Feldman MD, Collman RG, Rodino KG, Kelly BJ, Bushman FD. SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021. medRxiv. Cold Spring Harbor Laboratory; 2021 Nov 17;2021.10.18.21264623. Available from: http://dx.doi.org/10.1101/2021.10.18.21264623 PMCID: PMC8547530

Zhang HL, Kelly BJ, David MZ, Lautenbach E, Huang E, Bekele S, Tolomeo P, Reesey E, Loughrey S, Pegues D, Ziegler MJ, CDC Prevention Epicenters Program. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) surface contamination in staff common areas and impact on healthcare worker infection: Prospective surveillance during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021 Nov 15;1–4. Available from: http://dx.doi.org/10.1017/ice.2021.468 PMCID: PMC8649357

Rhee RL, Lu J, Bittinger K, Lee J-J, Mattei LM, Sreih AG, Chou S, Miner JJ, Cohen NA, Kelly BJ, Lee H, Grayson PC, Collman RG, Merkel PA. Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2021 Sep;73(9):1703–1712. Available from: http://dx.doi.org/10.1002/art.41723 PMCID: PMC8403103

Kelly BJ, Bekele S, Loughrey S, Huang E, Tolomeo P, David MZ, Lautenbach E, Han JH, Ziegler MJ, CDC Prevention Epicenters Program. Healthcare microenvironments define multidrug-resistant organism persistence. Infect Control Hosp Epidemiol. Cambridge University Press; 2021 Aug 24;1–7. Available from: http://dx.doi.org/10.1017/ice.2021.323 PMID: 34425925

Harrigan JJ, Abdallah H, Clarke EL, Oganisian A, Roy JA, Lautenbach E, Reesey E, Wernovsky M, Tolomeo P, Morawski Z, Jacob J, Grippi MA, Kelly BJ. Respiratory microbiome disruption and risk for ventilator-associated lower respiratory tract infection. Clin Infect Dis. 2021 Aug 7. Available from: http://dx.doi.org/10.1093/cid/ciab678 PMID: 34363467

Abdallah HO, Weingart MF, Fuller R, Pegues D, Fitzpatrick R, Kelly BJ. Subglottic suction frequency and adverse ventilator-associated events during critical illness. Infect Control Hosp Epidemiol. 2021 Jul;42(7):826–832. Available from: http://dx.doi.org/10.1017/ice.2020.1298 PMCID: PMC8272736

Richard-Greenblatt M, Ziegler MJ, Bromberg V, Huang E, Abdallah H, Tolomeo P, Lautenbach E, Glaser L, Kelly BJ. Quantifying the Impact of Nasopharyngeal Specimen Quality on Severe Acute Respiratory Syndrome Coronavirus 2 Test Performance. Open Forum Infect Dis. Oxford University Press; 2021 Jun;8(6):ofab235. Available from: http://dx.doi.org/10.1093/ofid/ofab235 PMCID: PMC8136075

Richard-Greenblatt M, Ziegler MJ, Bromberg V, Huang E, Abdallah H, Tolomeo P, Lautenbach E, Glaser L, Kelly BJ. Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity. medRxiv. Cold Spring Harbor Laboratory Press; 2020 Dec 11;2020.12.09.20246520. Available from: http://dx.doi.org/10.1101/2020.12.09.20246520 PMCID: PMC7743104

Redding LE, Kelly BJ, Stefanovski D, Lautenbach JK, Tolomeo P, Cressman L, Gruber E, Meily P, Lautenbach E. Pet Ownership Protects Against Recurrence of Clostridioides difficile Infection. Open Forum Infect Dis. 2020 Jan;7(1):ofz541. Available from: http://dx.doi.org/10.1093/ofid/ofz541 PMCID: PMC6969483

Berry ASF, Kelly BJ, Barnhart D, Kelly DJ, Beiting DP, Baldassano RN, Redding LE. Gut microbiota features associated with Clostridioides difficile colonization in puppies. PLoS One. 2019 Aug 30;14(8):e0215497. Available from: http://dx.doi.org/10.1371/journal.pone.0215497 PMCID: PMC6716646

Ziegler M, Han JH, Landsburg D, Pegues D, Reesey E, Gilmar C, Gorman T, Bink K, Moore A, Kelly BJ, CDC Prevention Epicenters Program. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy. Open Forum Infect Dis. 2019 Jul;6(7):ofz252. Available from: http://dx.doi.org/10.1093/ofid/ofz252 PMCID: PMC6602896

Kelly BJ, Lautenbach E, Han JH, Centers for Disease Control and Prevention Healthcare Associated Infection Prevention Epicenters Program. The authors reply. Critical care medicine. 2019. p. e275–e276. Available from: http://dx.doi.org/10.1097/CCM.0000000000003587 PMID: 30768528

Knecht VR, McGinniss JE, Shankar HM, Clarke EL, Kelly BJ, Imai I, Fitzgerald AS, Bittinger K, Bushman FD, Collman RG. Molecular analysis of bacterial contamination on stethoscopes in an intensive care unit. Infect Control Hosp Epidemiol. 2019 Feb;40(2):171–177. Available from: http://dx.doi.org/10.1017/ice.2018.319 PMCID: PMC6581638

Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH, Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis. Crit Care Med. 2018 Jul;46(7):1106–1113. Available from: http://dx.doi.org/10.1097/CCM.0000000000003137 PMCID: PMC6010038

Agarwal R, Bartsch SM, Kelly BJ, Prewitt M, Liu Y, Chen Y, Umscheid CA. Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis. Clin Microbiol Infect. 2018 Apr;24(4):361–368. Available from: http://dx.doi.org/10.1016/j.cmi.2017.08.028 PMCID: PMC5925741

Kelly BJ, Tebas P. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Chest. 2018 Jan;153(1):266–277. Available from: http://dx.doi.org/10.1016/j.chest.2017.09.002 PMCID: PMC5812771

Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH, Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis. Diagn Microbiol Infect Dis. 2016 May;85(1):109–115. Available from: http://dx.doi.org/10.1016/j.diagmicrobio.2016.01.003 PMCID: PMC4841711

Kelly BJ, Imai I, Bittinger K, Laughlin A, Fuchs BD, Bushman FD, Collman RG. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome. 2016 Feb 11;4(1):7. Available from: http://dx.doi.org/10.1186/s40168-016-0151-8 PMCID: PMC4750361

Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman RG, Bushman FD, Li H. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics. 2015 Aug 1;31(15):2461–2468. Available from: http://dx.doi.org/10.1093/bioinformatics/btv183 PMCID: PMC4514928

Brady T, Kelly BJ, Male F, Roth S, Bailey A, Malani N, Gijsbers R, O’Doherty U, Bushman FD. Quantitation of HIV DNA integration: effects of differential integration site distributions on Alu-PCR assays. J Virol Methods. 2013 Apr;189(1):53–57. Available from: http://dx.doi.org/10.1016/j.jviromet.2013.01.004 PMCID: PMC3608829

Khiabanian H, Holmes AB, Kelly BJ, Gururaj M, Hripcsak G, Rabadan R. Signs of the 2009 influenza pandemic in the New York-Presbyterian Hospital electronic health records. PLoS One. 2010 Sep 9;5(9). Available from: http://dx.doi.org/10.1371/journal.pone.0012658 PMCID: PMC2936568

Yu M, Kumar TRS, Nkrumah LJ, Coppi A, Retzlaff S, Li CD, Kelly BJ, Moura PA, Lakshmanan V, Freundlich JS, Valderramos J-C, Vilcheze C, Siedner M, Tsai JH-C, Falkard B, Sidhu ABS, Purcell LA, Gratraud P, Kremer L, Waters AP, Schiehser G, Jacobus DP, Janse CJ, Ager A, Jacobs WR Jr, Sacchettini JC, Heussler V, Sinnis P, Fidock DA. The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. Cell Host Microbe. 2008 Dec 11;4(6):567–578. Available from: http://dx.doi.org/10.1016/j.chom.2008.11.001 PMCID: PMC2646117